Paula Caldas-Fernandez
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Varnimcabtagene autoleucel (ARI-0001) in relapsed or refractory mantle cell lymphoma.
Journal: HemaSphere
Published: December 28, 2025
Real-world resource utilization, toxicity management, and efficacy outcomes of CD20 × CD3 bispecific antibodies in B-cell lymphoma: A study from the GELTAMO network.
Journal: HemaSphere
Published: December 11, 2025
Prognostic value of liver stiffness measurement for complications after allogeneic transplant with post-transplant cyclophosphamide.
Journal: Frontiers in immunology
Published: September 04, 2025
ICANS risk model in CD19 CAR-T therapy: insights from serum and CSF cytokine profiling.
Journal: Bone marrow transplantation
Published: March 04, 2025
Chimeric antigen receptor copies in cell-free DNA predict relapse in aggressive B-cell lymphoma patients treated with CAR T-cell therapy.
Journal: British journal of haematology
Published: September 20, 2024
Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study.
Journal: Cancers
Published: January 21, 2024
Digital PCR Improves Sensitivity and Quantification in Monitoring CAR-T Cells in B Cell Lymphoma Patients.
Journal: Transplantation and cellular therapy
Published: September 27, 2023
Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy.
Journal: Frontiers in immunology
Published: February 14, 2023
Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide.
Journal: Annals of hematology
Published: November 28, 2022
Allogeneic CD34-selected stem cell boost as salvage treatment of life-threatening infection and severe cytopenias after CAR-T cell therapy.
Journal: Transfusion
Published: March 17, 2022
Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC.
Journal: Transplantation and cellular therapy
Published: October 11, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026